Prevention of maternal Rh sensitization: anti-Rh immune globulin.
Explore the source record for details and available documents.
SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Seventeen severely Rh-sensitized women were treated with promethazine hydrochloride (Phenergan) in 18 pregnancies, according to a protocol described by Gusdon et al. There was an unequivocal amelioration of the disease process in 10 of the pregnancies. In 9 of these 10 pregnancies, the infant survived. In 4 of the pregnancies, promethazine proved an unnecessary therapy as the infants were Rh negative. Promethazine may or may not have been helpful in 2 pregnancies, both of which resulted in live-born infants. One pregnancy resulted in intrauterine fetal death subsequent to an intrauterine transfusion. This infant was later shown to have multiple congenital anomalies incompatible with life. In a subsequent pregnancy, the mother was again treated with promethazine and had a normal infant who survived after exchange transfusions. The one loss of a live-born infant resulted from a cardiac arrest during an exchange transfusion. On the basis of these observations, the authors agree with Gusdon et al that promethazine does have an ameliorating effect on Rh-sensitized pregnancies.
Explore the source record for details and available documents.
Sera from Rh-sensitized women representing presumable failure of the prophylactic treatment with IgG anti-D (Rh) have been examined for activity against allotype markers on IgG1. Antiallotype antibodies were found with increased frequency compared with a nonsensitized control. In general, however, interference of antiallotype antibodies is not considered to be a great risk of Rh prophylaxis at present. Some requirements which, in this context, may be of importance to the composition and dose of the IgG anti-D-containing preparations used are stressed.
Five Rh-sensitized pregnant women between 23 and 30 weeks gestation, with a poor obstetric history and initially high delta A450 values, were treated with weekly doses of 24 mg of dexamethasone over a period of 2-7 weeks to enhance fetal lung maturation. Four women showed a gradual decline in delta A450 during the treatment. All five deliveries were delayed until fetal lung maturity was confirmed by amniotic fluid lecithin/sphingomyelin (L/S) ratio and all five fetuses survived. It is possible that high doses of dexamethasone delayed the anticipated intrauterine deterioration of the fetuses and may have prevented the need for intrauterine transfusions.
The antenatal management of the Rh-sensitized woman is aimed at delivery of a living child with an optimum chance of survival. The author describes the improved methods of management that have dramatically reduced associated perinatal wastage and then goes on to describe the continuing search for new, more effective, and less invasive means of treating the Rh-sensitized pregnancy.
Three primigravidas developed Rh sensitization after unexplained third-trimester fetal death. One patient manifested sensitization after the diagnosis of fetal death had been made but before delivery occurred. The other two demonstrated anti-D antibodies early in the next pregnancy, despite having received postpartum Rh immunoglobulin. Unsensitized Rh-negative women with unexplained third-trimester fetal death should be screened routinely for fetomaternal hemorrhage when fetal death is discovered, so that adequate prophylaxis against Rh sensitization can be given.
In anticipation of elective premature delivery (32 to 34 weeks of gestation), five Rh-sensitized pregnant women were given hydrocortisone succinate for enhancement of fetal lung maturation. Serial amniocenteses were performed and an abrupt drop in the optical density at 450 millimicron (OD450) was observed in all cases immediately after administration of the steroid. Two infants in whom the OD450 remained low were followed safely to term. The others were delivered prematurely. All infants were Rh-sensitized and required one or more exchange transfusions, and all survived. It is tempting to speculate that glucocorticoids alter the antigen-antibody affinity and inhibit splenic macrophage sequestration, thus reducing erythrocyte destruction. Maternal steroid administration may prove to be therapeutic in the management of Rh-sensitization, but until its mechanisms are further delineated, extreme caution must be used in the interpretation of OD450 changes.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A study of the incidence of Rh-sensitization showed a 6.5% incidence of anti-D appearing for the first time during the last trimester of pregnancy. In 24 of the 29 subjects these antibodies were weak, and were found only when a sensitive technique using enzyme-treated Rh-deletion test cells was employed. The remaining five, however, had high-titre antibodies, which were associated with a positive Coombs test on cord blood.Rh-immune globulin administered at delivery resulted in disappearance of the anti-D in all but one of the subjects with weak antibody to whom it was given, suggesting that this treatment can reverse early sensitization. There was no effect when Rh-immune globulin was given to one subject with a high anti-D titre.Since sensitization has been found to occur frequently during the last trimester of pregnancy, an antenatal schedule of prophylaxis is advocated.
Among the most recent methods for investigation of proteins in biological fluids SDS polyacrilamide-gel-electrophoresis (SDS-PAGE) and isoelectrofocusing (IEF) have recently been introduced into laboratory practice. The present investigation was performed on 14 samples of amniotic fluid obtained during the third trimester in pregnancies complicated by Rh-sensitization and polyhydramnios in which protein concentration was higher than in normal pregnancies. The obtained results suggest that IEF analysis seems to have a selective advantage in allowing the separation of bands which cannot easily be recognized with SDS electrophoresis. These bands detected by IEF and present in amniotic fluid during late pregnancy seem to be related to some molecular weight lipoprotein fractions and we suggest that they might be used as a possible marker for monitoring fetal lung maturation. In conclusion we think that it would be of great interest to evaluate the usefulness of IEF analysis in examining amniotic fluid obtained during pregnancies complicated by polyhydramnios and Rh-sensitization.
This paper delineates the results of analysis of 234 Rh-sensitized pregnancies. It is now possible to predict the outcome in an Rh-isoimmunized pregnancy based only on the mean amniotic fluid, delta 450. This is an improvement over past methods since it does not depend upon calculation of weeks of pregnancy.
Explore the source record for details and available documents.
Explore the source record for details and available documents.